Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?
Bicycle Therapeutics Ownership Summary
Bicycle Therapeutics is owned by 59.46% institutional investors, 1.40% insiders, and 39.14% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.72% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.58% of its assets in Bicycle Therapeutics shares.
BCYC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bicycle Therapeutics | 59.46% | 1.40% | 39.14% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 10.89M | 15.72% | $75.65M |
| Fcpm iii services b.v. | 3.45M | 4.99% | $23.99M |
| Armistice capital | 2.80M | 4.04% | $19.46M |
| Westfield capital management co lp | 2.78M | 4.01% | $19.32M |
| Siren | 2.01M | 2.91% | $13.99M |
| Morgan stanley | 1.23M | 2.89% | $24.93M |
| Point72 asset management | 1.77M | 2.56% | $12.32M |
| Price t rowe associates inc /md/ | 1.59M | 2.30% | $22.19M |
| Long focus capital management | 1.32M | 1.90% | $9.16M |
| Deep track capital, lp | 1.20M | 1.74% | $8.36M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tybourne capital management (hk) | 993.74K | 20.00% | $6.91M |
| Fcpm iii services b.v. | 3.45M | 6.50% | $23.99M |
| Aquilo capital management | 171.69K | 2.61% | $1.46M |
| Nan fung group | 68.94K | 0.76% | $479.15K |
| Baker bros. advisors lp | 10.89M | 0.73% | $75.65M |
| Siren | 2.01M | 0.72% | $13.99M |
| Palo alto investors lp | 248.93K | 0.37% | $1.73M |
| Long focus capital management | 1.32M | 0.35% | $9.16M |
| Armistice capital | 2.80M | 0.34% | $19.46M |
| Deep track capital, lp | 1.20M | 0.27% | $8.36M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Acadian asset management | 698.50K | 0.01% | 572.44K |
| Deep track capital, lp | 1.20M | 0.27% | 436.23K |
| Tybourne capital management (hk) | 993.74K | 20.00% | 417.40K |
| Millennium management | 453.43K | 0.00% | 276.67K |
| Eversept partners, lp | 211.47K | 0.14% | 211.47K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -3.25M |
| Point72 asset management | 1.77M | 0.02% | -1.92M |
| Ra capital management | - | - | -1.09M |
| Polar capital | - | - | -1.00M |
| First light asset management | - | - | -967.01K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Eversept partners, lp | 211.47K | 0.14% | 211.47K | $1.47M |
| Soleus capital management | 100.00K | 0.05% | 100.00K | $695.00K |
| Dynamic technology lab private | 45.95K | 0.04% | 45.95K | $320.00K |
| Paloma partners management | 39.25K | 0.04% | 39.25K | $272.79K |
| Alps advisors | 25.76K | 0.00% | 25.76K | $179.01K |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
| Mather group, llc. | -5.00 |
| Northwestern mutual wealth management | -5.00 |
| Steward partners investment advisory | -10.00 |
| Eversource wealth advisors | -13.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 115 | 18.56% | 41,177,900 | -1.34% | 59 | 1.63% | 66 | 53.49% | 21 | -30.00% |
| Mar 31, 2025 | 1 | -99.00% | 68,943 | -99.84% | - | 0.00% | - | -100.00% | - | -100.00% |
| Dec 31, 2024 | 99 | -10.00% | 41,889,682 | 3.58% | 60 | 1.77% | 44 | -16.98% | 36 | 12.50% |
| Sep 30, 2024 | 110 | 1.85% | 40,440,427 | 1.84% | 58 | 1.00% | 55 | -9.84% | 32 | 28.00% |
| Jun 30, 2024 | 107 | 11.46% | 39,708,441 | 30.36% | 93 | 1.81% | 60 | 42.86% | 25 | -24.24% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 1.09M | 1.58% | -41.23K |
| Harbor Small Cap Growth Instl | 970.00K | 1.40% | -30.82K |
| Westfield Capital Mgt Co Sm-Cap Gr Eq | 970.00K | 1.40% | -30.82K |
| Candriam Eqs L Biotech C USD Cap | 805.24K | 1.16% | - |
| BNP Paribas Health Cr Innovtr Cl Cap | 567.98K | 0.82% | -563.00 |
| Principal SmallCap R5 | 538.99K | 0.78% | 200.69K |
| Candriam Global Equities Oncology | 492.11K | 0.71% | 125.18K |
| BNP Paribas US Small Cap ClassicC | 476.45K | 0.69% | 1.24K |
| BNP Paribas US Small Cap Classic R | 468.06K | 0.68% | -9.43K |
| Belfius Equities Cure C Cap | 367.15K | 0.53% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 03, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | $23.76K |
| Jul 02, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | $16.08K |
| Jul 02, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | $5.85K |
| Jul 03, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | $7.19K |
| Jul 02, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | $8.15K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 11 |
| 2025 Q2 | - | 11 |
| 2025 Q1 | - | 15 |
| 2024 Q4 | 10 | 11 |
| 2024 Q3 | - | 7 |
BCYC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools